AbbVie is a new biopharmaceutical company with the expertise and financial performance of an established pharmaceutical leader. Through a targeted, patient-centric approach to research & development, AbbVie accelerates new scientific discoveries to address some of the most complex diseases and contribute to the sustainability of health care systems around the world.
Here's a high-level overview about our business.
|Chairman and CEO||Richard A. Gonzalez|
|Corporate Headquarters||North Chicago, Illinois, USA|
|Business||Specialty-focused, research-based biopharmaceutical company|
|Stock Exchange Listing||New York [ABBV:NYSE]|
|2015 Revenue||$22.8 billion|
AbbVie is a global healthcare company whose passion lies in developing advanced therapies to address the world’s most difficult health problems.
Visit our US products page for prescribing information »
Lake Country, Illinois, USA
Worcester, Massachusetts, USA
Redwood City, California, USA
Sunnyvale, California, USA (Pharmacyclics)
Cambridge, Massachusetts, USA (Neuroscience)
San Francisco, California (Stemcentrx)
Focus on immunology, oncology, neurology, virology
|Countries Where Our Products Help Patients||170+|
|Primary Research and Manufacturing Facilities||13|